Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The goal of this clinical trial is to study the addition of Acalabrutinib to standard R-miniCHOP in older adults with DLBCL. The main question it aims to answer is whether progression free survival kann be prolonged with the addition of Acalabrutinib. Participants will be randomised to receive either R-miniCHOP alone or R-miniCHOP with Acalabrutinib.
Epistemonikos ID: 30c6cfc9bdbb8e6984afe7f6f393ae6ab3268ad0
First added on: Feb 19, 2024